Survey shows pharmacists’ loyalty to patients regardless of weather
Despite a challenging 2009-10 winter, the majority of pharmacists across 26 states (79% of respondents) that were affected by the snow largely managed to keep standard business hours, according to a survey conducted by the National Community Pharmacists Association. More....

First direct thrombin inhibitor cleared for DVT prevention
The FDA-approved desirudin for injection (Iprivask, Canyon Pharmaceuticals), now available, marks the first direct thrombin inhibitor (DTI) available for the prevention of deep vein thrombosis (DVT).” More...

Transdermal patch in development stages may prove beneficial in migraine treatment
Data from a phase-3 trial investigating a transdermal patch (Zelrix, NuPathe) for the management of acute migraine showed the patch met the primary efficacy endpoint of improvement in pain freedom for 2 hours post-patch application. More...

Opioid analgesic on market for cancer pain management
An FDA-approved, oral transmucosal fentanyl citrate and opioid analgesic (Mallinckrodt Inc., a Covidien company) for cancer pain management, is being launched. FDA cleared the Abbreviated New Drug Application (ANDA) for the generic substance in October 2009. More...

Injection pen will aid those with growth hormone-related conditions
Somatropin [rDNA origin] injection (Norditropin FlexPro, Novo Nordisk), a pre-filled injection pen for use in children and adults with growth hormone disorders, will be available this spring, based on recent FDA approval. More...

Rep. Marion Berry garners NACDS leadership award
The National Association of Chain Drug Stores (NACDS) awarded Rep. Marion Berry the NACDS Congressional Leadership Award for his ongoing support of pharmacy. More...